{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T22:55:34Z","timestamp":1782600934805,"version":"3.54.5"},"reference-count":37,"publisher":"Medical Association of Nippon Medical School","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nippon Med Sch"],"published-print":{"date-parts":[[2023,2,25]]},"DOI":"10.1272\/jnms.jnms.2023_90-105","type":"journal-article","created":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T22:15:52Z","timestamp":1669328152000},"page":"126-135","source":"Crossref","is-referenced-by-count":2,"title":["Epstein-Barr Virus-Related Hemophagocytic Lymphohistiocytosis with Central Nervous System Symptoms"],"prefix":"10.1272","volume":"90","author":[{"given":"Masahiro","family":"Sakaguchi","sequence":"first","affiliation":[{"name":"Department of Hematology, Nippon Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasunobu","family":"Nagata","sequence":"additional","affiliation":[{"name":"Department of Hematology, Nippon Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Terasaki","sequence":"additional","affiliation":[{"name":"Department of Analytic Human Pathology, Nippon Medical School"},{"name":"Division of Pathology, Nippon Medical School Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Takeyoshi","sequence":"additional","affiliation":[{"name":"Department of Hematology, Nippon Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunichi","family":"Yasuda","sequence":"additional","affiliation":[{"name":"Department of Hematology, Nippon Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"Honma","sequence":"additional","affiliation":[{"name":"Department of Hematology, Nippon Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryosuke","family":"Kinoshita","sequence":"additional","affiliation":[{"name":"Department of Hematology, Nippon Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Marumo","sequence":"additional","affiliation":[{"name":"Department of Hematology, Nippon Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshio","family":"Asayama","sequence":"additional","affiliation":[{"name":"Department of Hematology, Nippon Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"Yui","sequence":"additional","affiliation":[{"name":"Department of Hematology, Nippon Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Wakita","sequence":"additional","affiliation":[{"name":"Department of Hematology, Nippon Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muneo","family":"Okamoto","sequence":"additional","affiliation":[{"name":"Department of Hematology, Nippon Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Kajimoto","sequence":"additional","affiliation":[{"name":"Department of Analytic Human Pathology, Nippon Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Inokuchi","sequence":"additional","affiliation":[{"name":"Department of Hematology, Nippon Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Yamaguchi","sequence":"additional","affiliation":[{"name":"Department of Hematology, Nippon Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"21","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Filipovich AH. Hemophagocytic lymphohistiocytosis (HLH) and related disorders. Hematology Am Hematol Educ Program [Internet]. 2009;2009:127-31. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20008190","DOI":"10.1182\/asheducation-2009.1.127"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. La Ros\u00e9e P, Horne A, Hines M, et al. Recommendations for the management of hemophagocytic lymphohistiocytosis in adults. Blood [Internet]. 2019;133 (23):2465-77. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/30992265","DOI":"10.1182\/blood.2018894618"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Maakaroun NR, Moanna A, Jacob JT, Albrecht H. Viral infections associated with haemophagocytic syndrome. Rev Med Virol [Internet]. 2010;20 (2):93-105. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20127750","DOI":"10.1002\/rmv.638"},{"key":"4","unstructured":"4. Imashuku S. Differential diagnosis of hemophagocytic syndrome: underlying disorders and selection of the most effective treatment. Int J Hematol [Internet]. 1997;66 (2):135-51. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9277044"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Klein C, Kleinschmidt-DeMasters BK, Liang X, Stence N, Tuder RM, Moore BE. A review of neuropathological features of familial and adult hemophagocytic lymphohistiocytosis. J Neuropathol Exp Neurol [Internet]. 2019;78 (3):197-208. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/30726926","DOI":"10.1093\/jnen\/nlz001"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6. Hiddemann W, Kneba M, Dreyling M, et al. Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP alone: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group. Blood [Internet]. 2005;106 (12):3725-32. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16123223","DOI":"10.1182\/blood-2005-01-0016"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Henter JI, Horne A, Aric\u00f3 M, et al. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatric blood &amp; cancer [Internet]. 2007;48 (2):124-31. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16937360","DOI":"10.1002\/pbc.21039"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Henter JI, Samuelsson-Horne A, Aric\u00f3 M, et al. Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation. Blood [Internet]. 2002;100 (7):2367-73. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12239144","DOI":"10.1182\/blood-2002-01-0172"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Bergsten E, Horne A, Aric\u00f3 M, et al. Confirmed efficacy of etoposide and dexamethasone in HLH treatment: long-term results of the cooperative HLH-2004 study. Blood [Internet]. 2017;130 (25):2728-38. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28935695","DOI":"10.1182\/blood-2017-06-788349"},{"key":"10","doi-asserted-by":"publisher","unstructured":"10. Yanagisawa R, Nakazawa Y, Matsuda K, et al. Outcomes in children with hemophagocytic lymphohistiocytosis treated using HLH-2004 protocol in Japan. International journal of hematology [Internet]. 2019;109 (2):206-13. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/30535855","DOI":"10.1007\/s12185-018-02572-z"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Yildiz H, Van Den Neste E, Defour JP, Danse E, Yombi JC. Adult haemophagocytic lymphohistiocytosis: a Review. QJM [Internet]. 2020;hcaa011. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/31943120","DOI":"10.1093\/qjmed\/hcaa011"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Ehl S, Astigarraga I, von Bahr Greenwood T, et al. Recommendations for the use of etoposide-based therapy and bone marrow transplantation for the treatment of HLH: Consensus statements by the HLH Steering Committee of the Histiocyte Society. J Allergy Clin Immunol Pract [Internet]. 2018;6 (5):1508-17. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/30201097","DOI":"10.1016\/j.jaip.2018.05.031"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Gratton SM, Powell TR, Theeler BJ, Hawley JS, Amjad FS, Tornatore C. Neurological involvement and characterization in acquired hemophagocytic lymphohistiocytosis in adulthood. J Neurol Sci [Internet]. 2015;357 (1-2):136-42. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26198020","DOI":"10.1016\/j.jns.2015.07.017"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Cai G, Wang Y, Liu X, Han Y, Wang Z. Central nervous system involvement in adults with haemophagocytic lymphohistiocytosis: a single-center study. Ann Hematol [Internet]. 2017;96 (8):1279-85. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28589450","DOI":"10.1007\/s00277-017-3035-5"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Yonese I, Sakashita C, Imadome KI, et al. Nationwide survey of systemic chronic active EBV infection in Japan in accordance with the new WHO classification. BloodAadv [Internet]. 2020;4 (13):2918-26. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32598475","DOI":"10.1182\/bloodadvances.2020001451"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Oyama T, Yamamoto K, Asano N, et al. Age-related EBV-associated B-cell lymphoproliferative disorders constitute a distinct clinicopathologic group: a study of 96 patients. Clin Cancer Res [Internet]. 2007;13 (17):5124-32. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17785567","DOI":"10.1158\/1078-0432.CCR-06-2823"},{"key":"17","doi-asserted-by":"publisher","unstructured":"17. Park S, Lee J, Ko YH, et al. The impact of Epstein-Barr virus status on clinical outcome in diffuse large B-cell lymphoma. Blood [Internet]. 2007;110 (3):972-8. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17400912","DOI":"10.1182\/blood-2007-01-067769"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Chuang SS, Ichinohasama R, Yang CC, et al. Multicentric primary intestinal EBV-positive diffuse large B cell lymphoma of the elderly presenting with perforation. Int J Hematol [Internet]. 2010;91 (3):534-8. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20155338","DOI":"10.1007\/s12185-010-0512-1"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Wada N, Ikeda J, Hori Y, et al. Epstein-barr virus in diffuse large B-Cell lymphoma in immunocompetent patients in Japan is as low as in Western Countries. J Med Virol [Internet]. 2011;83 (2):317-21. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21181929","DOI":"10.1002\/jmv.21967"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Ahn JS, Yang DH, Choi YD, et al. Clinical outcome of elderly patients with Epstein-Barr virus positive diffuse large B-cell lymphoma treated with a combination of rituximab and CHOP chemotherapy. Am J Hematol [Internet]. 2013;88 (9):774-9. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23760676","DOI":"10.1002\/ajh.23507"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Pan Y, Meng B, Zhang H, et al. Low incidence of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly in Tianjin, northern China. Leuk Lymphoma [Internet]. 2013;54 (2):298-303. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22830615","DOI":"10.3109\/10428194.2012.715347"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Chang ST, Lu YH, Lu CL, et al. Epstein-Barr virus is rarely associated with diffuse large B cell lymphoma in Taiwan and carries a trend for a shorter median survival time. J Clin Pathol [Internet]. 2014;67 (4):326-32. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24218026","DOI":"10.1136\/jclinpath-2013-201905"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Sato A, Nakamura N, Kojima M, et al. Clinical outcome of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly in the rituximab era. Cancer Sci [Internet]. 2014;105 (9):1170-5. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24974976","DOI":"10.1111\/cas.12467"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Okamoto A, Yanada M, Miura H, et al. Prognostic significance of Epstein-Barr virus DNA detection in pretreatment serum in diffuse large B-cell lymphoma. Cancer Sci [Internet]. 2015;106 (11):1576-81. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26353084","DOI":"10.1111\/cas.12812"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Liang JH, Lu TX, Tian T, et al. Epstein-Barr virus (EBV) DNA in whole blood as a superior prognostic and monitoring factor than EBV-encoded small RNA in situ hybridization in diffuse large B-cell lymphoma. Clin Microbiol Infect [Internet]. 2015;21 (6):596-602. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25743579","DOI":"10.1016\/j.cmi.2015.02.017"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Ishii E, Ohga S, Imashuku S, et al. Nationwide survey of hemophagocytic lymphohistiocytosis in Japan. Int J Hematol [Internet]. 2007;86 (1):58-65. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17675268","DOI":"10.1532\/IJH97.07012"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Kogawa K, Sato H, Asano T, et al. Prognostic factors of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children: report of the Japan Histiocytosis Study Group. Pediatric Blood Cancer [Internet]. 2014;61 (7):1257-62. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24535916","DOI":"10.1002\/pbc.24980"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Shiraishi A, Ohga S, Doi T, et al. Treatment choice of immunotherapy or further chemotherapy for Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. Pediatric Blood Cancer [Internet]. 2012;59 (2):265-70. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22183955","DOI":"10.1002\/pbc.24039"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Kikuta H, Sakiyama Y. Etoposide (VP-16) inhibits Epstein-Barr virus determined nuclear antigen (EBNA) synthesis. Br J Haematol [Internet]. 1995;90 (4):971-3. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7669686","DOI":"10.1111\/j.1365-2141.1995.tb05232.x"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Su IJ, Wang CH, Cheng AL, Chen RL. Hemophagocytic syndrome in Epstein-Barr virus-associated T-lymphoproliferative disorders: disease spectrum, pathogenesis, and management. Leuk Lymphoma [Internet]. 1995;19 (5-6):401-6. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8590839","DOI":"10.3109\/10428199509112197"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Imashuku S, Kuriyama K, Teramura T, et al. Requirement for etoposide in the treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. J Clin Oncol [Internet]. 2001;19 (10):2665-73. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11352958","DOI":"10.1200\/JCO.2001.19.10.2665"},{"key":"32","unstructured":"32. Imashuku S, Hibi S, Ohara T, et al. Effective control of Epstein-Barr virus-related hemophagocytic lymphohistiocytosis with immunochemotherapy. Histiocyte Society. Blood [Internet]. 1999;93 (6):1869-74. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10068659"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Imashuku S. Clinical features and treatment strategies of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. Crit Rev Oncol Hematol [Internet]. 2002;44 (3):259-72. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12467966","DOI":"10.1016\/S1040-8428(02)00117-8"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Johkura K, Momoo T, Kuroiwa Y. Thalamic involvement of Epstein-Barr virus encephalitis demonstrated by MRI. J Neurol [Internet]. 2003;250 (3):357-8. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12749320","DOI":"10.1007\/s00415-003-0977-4"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Shian WJ, Chi CS. Epstein-Barr virus encephalitis and encephalomyelitis: MR findings. Pediatr Radiol [Internet]. 1996;26 (9):690-3. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8781116","DOI":"10.1007\/BF01356839"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Horne A, Wickstr\u00f6m R, Jordan MB, et al. How to treat involvement of the central nervous system in hemophagocytic lymphohistiocytosis? Curr Treat Options Neurol [Internet]. 2017;19 (1):3. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28155064","DOI":"10.1007\/s11940-017-0439-4"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Jordan MB, Allen CE, Weitzman S, Filipovich AH, McClain KL. How I treat hemophagocytic lymphohistiocytosis. Blood [Internet]. 2011;118 (15):4041-52. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21828139","DOI":"10.1182\/blood-2011-03-278127"}],"container-title":["Journal of Nippon Medical School"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jnms\/90\/1\/90_JNMS.2023_90-105\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T04:57:03Z","timestamp":1715317023000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jnms\/90\/1\/90_JNMS.2023_90-105\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,25]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1272\/jnms.jnms.2023_90-105","relation":{},"ISSN":["1345-4676","1347-3409"],"issn-type":[{"value":"1345-4676","type":"print"},{"value":"1347-3409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,25]]},"article-number":"JNMS.2023_90-105"}}